‘DIVOC Labs’ – First Telemedicine diagnosis lab launched in India. Introducing Labs of the future – diagnostics test and results at home with accuracy in less than 20 minutes. Patients find home healthcare more efficient because it provides contact less treatment and diagnostics results.
It has also introduced at-home, instant diagnostics which would allow phlebotomists to conduct testing and deliver results right away. The ‘lab of the future’ has collaborated with United Kingdom laboratories to bring 21st century innovations into diagnostics. With faster results i.e within 20 minutes at home, DIVOC is also empowering and enabling the overall telemedicine segment in India. This innovation will enable a new generation of medicine where the operations can extend into peoples’ homes and the diagnostic continuum can empower a truly connected, omnipresent vision of health.
DIVOC Laboratories offer more than 500 tests including Clinical Chemistry, Clinical Microbiology, Hematology, Serology, Clinical Microscopy, Cytopathology and Molecular Biology. It also offers TRUNAAT, RT PCR and Antigen COVID Testing pending ICMR notifications and approvals.
DIVOC Health is formed to reverse the COVID-19 pandemic. Using innovative approaches and products, DIVOC envisions addressing the needs of the Indian healthcare sector. It is established by Dr Kanav Kahol, a renowned healthcare innovator who is a former PhD scientist and professor from Arizona State University and Mayo Clinic USA in partnership with Christopher Egerton Warburton (Edge) form Lions Global Head Partners UK. DIVOC Health is striving to address the immediate need of the country to have access to high quality COVID-19 tests. DIVOC is also working on healthcare delivery models to enable quality healthcare through technology.